Section one: Contracting authority
one.1) Name and addresses
NHS Birmingham and Solihull Integrated Care Board
NHS Birmingham and Solihull Integrated Care Board Alpha Tower, 8th Floor, Suffolk Street Queensway
Birmingham
B1 1TT
Contact
Kimberley Walker
Country
United Kingdom
Region code
UKG31 - Birmingham
Internet address(es)
Main address
https://www.birminghamsolihull.icb.nhs.uk/
Buyer's address
https://www.birminghamsolihull.icb.nhs.uk/
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Faecal Immunochemical Test (FIT) Service
two.1.2) Main CPV code
- 85145000 - Services provided by medical laboratories
two.1.3) Type of contract
Services
two.1.4) Short description
NHS Arden and Greater East Midlands CSU on behalf of the NHS Black Country Integrated Care Board intend to award a contract for the provision of a FIT (Faecal Immunochemical Testing) Service.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £2,547,420
two.2) Description
two.2.2) Additional CPV code(s)
- 85145000 - Services provided by medical laboratories
two.2.3) Place of performance
NUTS codes
- UKG3 - West Midlands
two.2.4) Description of the procurement
The successful Provider will deliver a FIT (Faecal Immunochemical Testing) Service with the aim of reducing mortality from bowel cancer for patients registered with a GP in the BSol area.
As a result of this Competitive Process, a Contract will be awarded to the successful Provider for a period of 2 years, commencing 01st July 2025, with the Commissioner having the option to extend the Contract for up to a further 2 years. The new service has been awarded to an existing Provider. It is anticipated that the service provision resulting from this Competitive Process will have a value of £2,547,420 for the contract period, which includes any exercised contract extensions.
two.2.5) Award criteria
Quality criterion - Name: Quality & Innovation / Weighting: 30.00%
Quality criterion - Name: Integration, Collaboration & Service Sustainability / Weighting: 22.00%
Quality criterion - Name: Improving Access, Reducing Health Inequalities & Facilitating Choice / Weighting: 08.00%
Quality criterion - Name: Social Value / Weighting: 10.00%
Cost criterion - Name: Value (Price) / Weighting: 30.00%
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2025/S 000-000368
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
19 May 2025
five.2.2) Information about tenders
Number of tenders received: 5
Number of tenders received from SMEs: 2
Number of tenders received from tenderers from other EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 5
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Bowel Cancer Screening Midlands and North West
St Cross Hospital Rugby
Coventry
CV22 5PX
Telephone
+44 1788663031
Country
United Kingdom
NUTS code
- UKG13 - Warwickshire
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £3,307,124
Total value of the contract/lot: £2,547,420
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight 02nd June 2025. Any representations should be sent via the Atamis messaging portal.
This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR.
The award decision-makers are the NHS Birmingham and Solihull Integrated Care Board. The decision to award the contract was made by the NHS Birmingham and Solihull Integrated Care Board. There were no declared of potential conflicts of interest of individuals making the award decision.
The scoring criteria for the Basic Selection Criteria Questions were either evaluated as Pass/Fail or For Information.
The Key Criteria Questions were evaluated as scored sub-weighted questions, as follows:
Quality & Innovation – 30.00%
Value (price) – 30.00%
Integration, Collaboration & Service Sustainability – 22.00%
Improving Access, Reducing Health Inequalities & Facilitating Choice – 08.00%
Social Value – 10.00%
Bowel Cancer Screening Midlands and North West received the highest combined overall weighted Key Criteria score out of 100.00%. Therefore, they are the preferred provider and awarded the contract (subject to agreement).
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom